A therapeutic study design was used to evaluate treatment with OLX‐07010 on the accumulation of tau aggregates in an aged mouse model of 4R tauopathy, homozygous female P301L tau JNPL3 mice (Figure 1). This evidence concerns the gene MAPT and tauopathy.